Acta Med. 2005, 48: 57-58
https://doi.org/10.14712/18059694.2018.32
Plasma Concentrations of Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor in Lymphoproliferative Disorders
References
1. A, Kantarjian H, Manshouri T et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 2000; 96(6):2240–5.
2. ML, Eccles SA, Tutton MG et al. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? Clin Cancer Res 2000; 6(8):3147–52.
3. NE, Bone ND, Tschumper RC et al. B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules. Leukemia 2002; 16(5): 911–9.
<https://doi.org/10.1038/sj.leu.2402467>
4. TM, Ho AD, Goldschmidt H et al. Angiogenesis in hematologic malignancies. Crit Rev Oncol Hematol 2003; 45(3):227–44.
<https://doi.org/10.1016/S1040-8428(02)00135-X>
5. L, Hájek R, Büchler T et al. Angiogenesis and antiangiogenic therapy in tumors. Vnitř Lék 2004; 12:930–8.
6. D, Vacca A, Dammacco F et al. Angiogenesis and anti-angiogenesis in hematological malignancies. J Hematother Stem Cell Res 2003; 12(1):11–22.
<https://doi.org/10.1089/152581603321210091>
7. Smolej L. Angiogenesis as a diagnostic and therapeutic target in hematological malignancies. Pracovni dny SZP 2004, Sedmihorky, Book of abstracts, 56–9.
8. Smolej L. Markers of Angiogenesis in Hematological Malignancies. 1st Morphological Postgraduate Workshop, Hradec Králové, 15.2.2005, Book of abstracts, 35.
9. NJ, Bottomley MJ, Watson CJ et al. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin Sci (Lond) 1998; 94(4):395–404.
<https://doi.org/10.1042/cs0940395>
